Eriksen, R.* ; White, M.C.* ; Dawed, A.Y.* ; Garcia Perez, I.* ; Posma, J.M.* ; Haid, M. ; Sharma, S. ; Prehn, C. ; Thomas, L.E.* ; Koivula, R.W.* ; Bizzotto, R.* ; Mari, A.* ; Giordano, G.N.* ; Pavo, I.* ; Schwenk, J.M.* ; De Masi, F.* ; Tsirigos, K.D.* ; Brunak, S.* ; Viñuela, A.* ; Mahajan, A.* ; McDonald, T.J.* ; Kokkola, T.* ; Rutters, F.* ; Beulens, J.* ; Muilwijk, M.* ; Blom, M.T.* ; Elders, P.* ; Hansen, T.H.* ; Fernandez-Tajes, J.* ; Jones, A.* ; Jennison, C.* ; Walker, M.* ; McCarthy, M.I.* ; Pedersen, O.* ; Ruetten, H.* ; Forgie, I.* ; Holst, J.J.* ; Thomsen, H.S.* ; Ridderstråle, M.* ; Bell, J.D.* ; Adamski, J. ; Franks, P.W.* ; Hansen, T.* ; Holmes, E.* ; Frost, G.* ; Pearson, E.R.*
The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like peptide-1: An IMI DIRECT study.
J. Clin. Endocrinol. Metab. 109, e1697-e1707 (2024)
CONTEXT: The role of glucagon-like peptide-1(GLP-1) in Type 2 diabetes (T2D) and obesity is not fully understood. OBJECTIVE: We investigate the association of cardiometabolic, diet and lifestyle parameters on fasting and postprandial GLP-1 in people at risk of, or living with, T2D. METHOD: We analysed cross-sectional data from the two Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) cohorts, cohort 1(n=2127) individuals at risk of diabetes; cohort 2 (n=789) individuals with new-onset of T2D. RESULTS: Our multiple regression analysis reveals that fasting total GLP-1 is associated with an insulin resistant phenotype and observe a strong independent relationship with male sex, increased adiposity and liver fat particularly in the prediabetes population. In contrast, we showed that incremental GLP-1 decreases with worsening glycaemia, higher adiposity, liver fat, male sex and reduced insulin sensitivity in the prediabetes cohort. Higher fasting total GLP-1 was associated with a low intake of wholegrain, fruit and vegetables inpeople with prediabetes, and with a high intake of red meat and alcohol in people with diabetes. CONCLUSION: These studies provide novel insights into the association between fasting and incremental GLP-1, metabolic traits of diabetes and obesity, and dietary intake and raise intriguing questions regarding the relevance of fasting GLP-1 in the pathophysiology T2D.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
GLP-1; type 2 diabetes; prediabetes; liver fat; obesity; insulin resistance; incretin; nutrition; diet; cardiometabolic markers; Mixed Meal; Glp-1; Secretion; Discovery; Cells; Risk
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
0021-972X
e-ISSN
1945-7197
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 109,
Heft: 9,
Seiten: e1697-e1707
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Endocrine Society
Verlagsort
Bethesda, Md.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Epidemiology (EPI)
POF Topic(s)
30201 - Metabolic Health
30202 - Environmental Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-505600-003
G-504091-002
Förderungen
Wellcome
Rutherford Fund Fellowship at Health Data Research (HDR) UK
NIHR Fellowship
Imperial College National Institute for Health Research (NIHR) BRC
European Union
Novo Nordisk Foundation
Swedish Research Council, Linnaeus
Swedish Foundation for Strategic Research
Lund University Diabetes Centre
Swedish Research Council
STAR Award Novo Nordisk
NIHR (Niddk)
Innovative Medicines Initiative Joint Undertaking
Copyright
Erfassungsdatum
2024-05-21